Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering
March 6 (Reuters) - Calidi Biotherapeutics Inc CLDI.A:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.